Presence of Akkermansiaceae in gut microbiome and immunotherapy effectiveness in patients with advanced non-small cell lung cancer

被引:42
作者
Grenda, Anna [1 ]
Iwan, Ewelina [2 ]
Chmielewska, Izabela [1 ]
Krawczyk, Pawel [1 ]
Giza, Aleksandra [2 ]
Bomba, Arkadiusz [2 ]
Frak, Malgorzata [1 ]
Rolska, Anna [1 ]
Szczyrek, Michal [1 ]
Kieszko, Robert [1 ]
Kucharczyk, Tomasz [1 ]
Jarosz, Bozena [3 ]
Wasyl, Dariusz [2 ]
Milanowski, Janusz [1 ]
机构
[1] Med Univ Lublin, Dept Pneumonol Oncol & Allergol, Jaczewskiego 8, PL-20954 Lublin, Poland
[2] Natl Vet Res Inst, Dept Omics Anal, Pulawy, Poland
[3] Med Univ Lublin, Chair & Dept Neurosurg & Pediat Neurosurg, Lublin, Poland
关键词
Akkermansiaceae; NSCLC; Response to immunotherapy; PD-1; PD-L1; Microbiome; MUCINIPHILA;
D O I
10.1186/s13568-022-01428-4
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
The significance of Akkermansia bacteria presence in gut micobiome, mainly Akkermansia mucinifila, is currently being investigated in the context of supporting therapy and marker for response to immunotherapy in cancer patients. It is indicated that patients with non-small cell lung cancer (NSCLC) treated with immune checkpoint inhibitors (ICIs) respond better to treatment if this bacterium is present in the intestine. We performed next-generation sequencing of the gut microbiome from patients treated in the first or second line therapy with anti-PD-1 (anti-programmed death 1) or anti-PD-L1 (anti-programmed death ligand 1) monoclonal antibodies. In our study group of 47 NSCLC patients, the percentage of Akkermansiaceae was higher in patients with disease stabilization and with partial response to immunotherapy compared to patients with disease progression. Moreover, we found that a higher percentage of Akkermansiaceae was present in patients with squamous cell carcinoma compared to adenocarcinoma. Our study showed that Akkermansiaceae could be supporting marker for response to immunotherapies in NSCLC patients, nonetheless further in-depth studies should be conducted in the role of Akkermansiaceae in cancer immunotherapy.
引用
收藏
页数:7
相关论文
共 31 条
[21]   Dietary Polyphenols Promote Growth of the Gut Bacterium Akkermansia muciniphila and Attenuate High-Fat Diet-Induced Metabolic Syndrome [J].
Roopchand, Diana E. ;
Carmody, Rachel N. ;
Kuhn, Peter ;
Moskal, Kristin ;
Rojas-Silva, Patricio ;
Turnbaugh, Peter J. ;
Raskin, Ilya .
DIABETES, 2015, 64 (08) :2847-2858
[22]   Gut microbiome influences efficacy of PD-1-based immunotherapy against epithelial tumors [J].
Routy, Bertrand ;
Le Chatelier, Emmanuelle ;
Derosa, Lisa ;
Duong, Connie P. M. ;
Alou, Maryam Tidjani ;
Daillere, Romain ;
Fluckiger, Aurelie ;
Messaoudene, Meriem ;
Rauber, Conrad ;
Roberti, Maria P. ;
Fidelle, Marine ;
Flament, Caroline ;
Poirier-Colame, Vichnou ;
Opolon, Paule ;
Klein, Christophe ;
Iribarren, Kristina ;
Mondragon, Laura ;
Jacquelot, Nicolas ;
Qu, Bo ;
Ferrere, Gladys ;
Clemenson, Celine ;
Mezquita, Laura ;
Masip, Jordi Remon ;
Naltet, Charles ;
Brosseau, Solenn ;
Kaderbhai, Coureche ;
Richard, Corentin ;
Rizvi, Hira ;
Levenez, Florence ;
Galleron, Nathalie ;
Quinquis, Benoit ;
Pons, Nicolas ;
Ryffel, Bernhard ;
Minard-Colin, Veronique ;
Gonin, Patrick ;
Soria, Jean-Charles ;
Deutsch, Eric ;
Loriot, Yohann ;
Ghiringhelli, Francois ;
Zalcman, Gerard ;
Goldwasser, Francois ;
Escudier, Bernard ;
Hellmann, Matthew D. ;
Eggermont, Alexander ;
Raoult, Didier ;
Albiges, Laurence ;
Kroemer, Guido ;
Zitvogel, Laurence .
SCIENCE, 2018, 359 (6371) :91-+
[23]   Increased rectal microbial richness is associated with the presence of colorectal adenomas in humans [J].
Sanapareddy, Nina ;
Legge, Ryan M. ;
Jovov, Biljana ;
McCoy, Amber ;
Burcal, Lauren ;
Araujo-Perez, Felix ;
Randall, Thomas A. ;
Galanko, Joseph ;
Benson, Andrew ;
Sandler, Robert S. ;
Rawls, John F. ;
Abdo, Zaid ;
Fodor, Anthony A. ;
Keku, Temitope O. .
ISME JOURNAL, 2012, 6 (10) :1858-1868
[24]   Resistance to PD-1/PD-L1 blockade cancer immunotherapy: mechanisms, predictive factors, and future perspectives [J].
Sun, Jin-Yu ;
Zhang, Dengke ;
Wu, Songquan ;
Xu, Min ;
Zhou, Xiao ;
Lu, Xiao-Jie ;
Ji, Jiansong .
BIOMARKER RESEARCH, 2020, 8 (01)
[25]   Five-Year Survival and Correlates Among Patients With Advanced Melanoma, Renal Cell Carcinoma, or Non-Small Cell Lung Cancer Treated With Nivolumab [J].
Topalian, Suzanne L. ;
Hodi, F. Stephen ;
Brahmer, Julie R. ;
Gettinger, Scott N. ;
Smith, David C. ;
McDermott, David F. ;
Powderly, John D. ;
Sosman, Jeffrey A. ;
Atkins, Michael B. ;
Leming, Philip D. ;
Spigel, David R. ;
Antonia, Scott J. ;
Drilon, Alexander ;
Wolchok, Jedd D. ;
Carvajal, Richard D. ;
McHenry, M. Brent ;
Hosein, Fareeda ;
Harbison, Christopher T. ;
Grosso, Joseph F. ;
Sznol, Mario .
JAMA ONCOLOGY, 2019, 5 (10) :1411-1420
[26]   The Resistance Mechanisms of Lung Cancer Immunotherapy [J].
Wang, Fen ;
Wang, Shubin ;
Zhou, Qing .
FRONTIERS IN ONCOLOGY, 2020, 10
[27]   Stool Microbiome and Metabolome Differences between Colorectal Cancer Patients and Healthy Adults [J].
Weir, Tiffany L. ;
Manter, Daniel K. ;
Sheflin, Amy M. ;
Barnett, Brittany A. ;
Heuberger, Adam L. ;
Ryan, Elizabeth P. .
PLOS ONE, 2013, 8 (08)
[28]   The Gut Microbiome Modulates Colon Tumorigenesis [J].
Zackular, Joseph P. ;
Baxter, Nielson T. ;
Iverson, Kathryn D. ;
Sadler, William D. ;
Petrosino, Joseph F. ;
Chen, Grace Y. ;
Schloss, Patrick D. .
MBIO, 2013, 4 (06)
[29]   The gut microbiome can be used to predict the gastrointestinal response and efficacy of lung cancer patients undergoing chemotherapy [J].
Zhang, Min ;
Zhou, Huan ;
Xu, Shanshan ;
Liu, Dan ;
Cheng, Ye ;
Gao, Bing ;
Li, Xiuhua ;
Chen, Jun .
ANNALS OF PALLIATIVE MEDICINE, 2020, 9 (06) :4211-4227
[30]   Specific gut microbiome signature predicts the early-stage lung cancer [J].
Zheng, Yajuan ;
Fang, Zhaoyuan ;
Xue, Yun ;
Zhang, Jian ;
Zhu, Junjie ;
Gao, Renyuan ;
Yao, Shun ;
Ye, Yi ;
Wang, Shihui ;
Lin, Changdong ;
Chen, Shiyang ;
Huang, Hsinyi ;
Hu, Liang ;
Jiang, Ge-Ning ;
Qin, Huanlong ;
Zhang, Peng ;
Chen, Jianfeng ;
Ji, Hongbin .
GUT MICROBES, 2020, 11 (04) :1030-1042